Abbott (NYSE: ABT) today announced new clinical data supporting its minimally invasive therapies for treating AFib.

Abbott’s Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an approval in Europe for its Volt system. Boston Scientific, Medtronic and ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...

Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib) Pulsed field ablation – or ...

VIENNA, Austria—The Volt pulsed-field ablation (PFA) system (Abbott) is safe and effective for pulmonary vein isolation in patients with atrial fibrillation (AF), according to results from the VOLT CE ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...